Ixchiq Vaccine Pulled From U.S. Market Amid Safety Concerns

By News Health
35 minutes Ago

(MedPage Today) — Vaccine maker Valneva will pull its chikungunya vaccine (Ixchiq) from the U.S. market after the FDA announced it would take further action to investigate the live-attenuated shot.
The FDA recently put the investigational new…

Source link : https://www.medpagetoday.com/infectiousdisease/vaccines/119506

Author :

Publish date : 2026-01-20 21:57:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Study: Helping Lupus Patients With Money Issues Improves Their Health

After My Breast Cancer Diagnosis, My Practice Became a Lab for Change

Medicare Paying Billions More for Medicare Advantage vs Traditional Enrollees

Coming Radiotracer Shortage; Dedicated Cardiometabolic Training; New PFA Catheter

Discussing Personalized Treatment Options in Breast Cancer

No Link Between Water Fluoridation, Birth Weight, Study Shows